Pharmaceuticals & Biotech

Pharma’s road map to patient centricity

By Hensley Evans, Sharon Suchotliff, and Jennifer Ntiri

June 13, 2019 | White Paper | 17-minute read

Pharma's road map to patient centricity

Over the past decade, the healthcare ecosystem has slowly moved toward the “triple aim”: better healthcare experiences, improved outcomes, and a slowing of the growth of overall healthcare costs. While many pharma companies have focused on educating and engaging patients to promote shared decision-making, improved experiences and adherence, and reduced costs, many still struggle to define what patient centricity means or how to link efforts to business results.


Here's what is behind the urgent shift toward patient centricity, where many pharma companies struggle to meet patient expectations and the five dimensions we’ve found to be most critical to maturing in patient centricity.

About the author(s)